Q2 was a mixed quarter wherein comparable sales were a tad below estimates while profitability met expectations. A slowdown in the PH segment, particularly in China, was the main reason behind the sales miss. However, we view this as a one-off and, given the seasonality of the business, we expect an acceleration in H2 18. Also, given a strong order book in D&T, we believe that the company would be able to meet its sales and profitability targets for FY18.
26 Jul 2018
Mixed results; momentum decelerates in Personal Health while Diagnostics remains robust
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Mixed results; momentum decelerates in Personal Health while Diagnostics remains robust
Koninklijke Philips N.V. (PHIA:WBO) | 0 0 1.5% | Mkt Cap: 29,653m
- Published:
26 Jul 2018 -
Author:
Sumit Sayal -
Pages:
4
Q2 was a mixed quarter wherein comparable sales were a tad below estimates while profitability met expectations. A slowdown in the PH segment, particularly in China, was the main reason behind the sales miss. However, we view this as a one-off and, given the seasonality of the business, we expect an acceleration in H2 18. Also, given a strong order book in D&T, we believe that the company would be able to meet its sales and profitability targets for FY18.